Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Eisner, F; Pichler, M; Goletz, S; Stoeger, H; Samonigg, H.
A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options.
J Clin Pathol. 2015; 68(12):1044-1046
Doi: 10.1136/jclinpath-2015-202996
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Eisner Florian
- Co-Autor*innen der Med Uni Graz
- Pichler Martin
- Samonigg Hellmut
- Stöger Herbert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Antineoplastic Agents - therapeutic use
- CHO Cells -
- Colorectal Neoplasms - drug therapy
- Colorectal Neoplasms - pathology
- Colorectal Neoplasms - surgery
- Cricetinae -
- Cricetulus -
- Disease-Free Survival -
- Female -
- Gene Expression Regulation, Neoplastic -
- Humans -
- Liver Neoplasms - secondary
- Lung Neoplasms - secondary
- Middle Aged -
- Receptor, ErbB-2 - immunology
- Remission Induction -
- Trastuzumab - therapeutic use